Liver-targeting drugs and their effect on blood glucose and hepatic lipids

The global epidemic of non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) and the high prevalence among individuals with type 2 diabetes has attracted the attention of clinicians specialising in liver disorders. Many drugs are in the pipeline for the treatment of NAFLD/NASH, and se...

Descripción completa

Detalles Bibliográficos
Autores principales: Gastaldelli, Amalia, Stefan, Norbert, Häring, Hans-Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187191/
https://www.ncbi.nlm.nih.gov/pubmed/33877366
http://dx.doi.org/10.1007/s00125-021-05442-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187191/
https://www.ncbi.nlm.nih.gov/pubmed/33877366
http://dx.doi.org/10.1007/s00125-021-05442-2

Ejemplares similares